Depatuxizumab (Anti-ERBB1 / EGFR / HER1)
Depatuxizumab (Anti-ERBB1 / EGFR / HER1) (A2887-GRP)
Products
Description
Depatuxizumab (anti-ERBB1/ EGFR / HER1) is a humanized monoclonal antibody (MoAb) against the human epidermal growth factor receptor (EGFR) with antineoplastic activity. MW: 144.54 KD.
Specifications
| Manufacturer | Selleck Chemicals LLC |
|---|---|
| Manufacturer Cat# | A2887 |
| Target | EGFR |